Facility-based prospective cohort study to evaluate Moringa stenopetala based diet consumption in management of diabetes and hypertension in South Ethiopia
Rattachement africain : Éthiopie, ca. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Moringa stenopetala is a multi-purpose tree known for its significant nutritional and medicinal properties. Existing investigational reports on the effects of Moringa stenopetala on lipid profile, blood pressure, and fasting blood glucose levels are exclusively based on laboratory studies utilizing experimental animal models. However, there is a lack of scientific evidence from either placebo-controlled randomized clinical trials or community- or health facility-based follow-up studies. Therefore, this follow-up study was undertaken to evaluate the effect of dietary Moringa stenopetala consumption on biochemical markers and clinical parameters for the management of diabetes and hypertension in adult patients. A facility-based prospective cohort study was conducted among patients with diabetes and hypertension receiving chronic care follow-up. The exposure group comprised patients who consumed Moringa stenopetala as a dietary component at Gidolie District Hospital, while the non-exposed group consisted of those who did not consume it at Chencha District Hospital. Blood samples (4–5 mL) was collected for serum lipid profile determination. Independent t-tests and one-way ANOVA were used to assess the mean differences in biochemical markers and clinical parameters. A P-value of less than 0.05, with a 95% confidence level, was considered to indicate a statistically significant effect. For participants on the Moringa stenopetala consuming based diet, mean serum cholesterol levels were 126.03 (95% CI: 118.49, 133.56), low-density lipoprotein (LDL) levels were 71.47 (95% CI: 65.80, 77.13), and triglyceride levels were 109.40 (95% CI: 102.66, 116.14). In contrast, participants on the non-moringa diet exhibited mean serum cholesterol levels of 145.59 (95% CI: 135.25, 155.93), LDL levels of 74.39 (95% CI: 71.02, 77.77), and triglyceride levels of 116.27 (95% CI: 110.61, 121.93). The differences in these lipid parameters between the two diet groups were statistically significant (p = 0.001). Regarding blood pressure, participants on the moringa diet had a mean systolic blood pressure of 127.83 (95% CI: 123.85, 131.80) and a mean diastolic blood pressure of 78.26 (95% CI: 76.14, 80.38). In comparison, participants on the non-moringa diet had a mean systolic blood pressure of 133.71 (95% CI: 129.50, 137.91) and a mean diastolic blood pressure of 81.24 (95% CI: 79.02, 83.45). These differences in blood pressure were also statistically significant (p < 0.001). Moringa stenopetala consumption as a diet can have a beneficial effect in the management of diabetes and hypertension when frequently taken together with standard therapies. Further studies like randomized clinical trials are recommended to determine the medicinal value of moringa stenopetala in the management of diabetes and hypertension.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Facility-based prospective cohort study to evaluate Moringa stenopetala based diet consumption in management of diabetes and hypertension in South Ethiopia
- Date Crossref
- 19/02/2026
- Éditeur
- Springer Science and Business Media LLC
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Debre Markos University Debre Markos University, Éthiopie (code pays fourni par la source)Université ou école supérieure
-
Arba Minch University Arba Minch University, Éthiopie (code pays fourni par la source)Université ou école supérieure
-
University of Ottawa pays non établi dans la noticeUniversité ou école supérieure
-
Addis Ababa University Addis Ababa University, Éthiopie (code pays fourni par la source)Université ou école supérieure
-
Ethiopian Public Health Institute Addis Ababa, Éthiopie (code pays fourni par la source)Structure de recherche
-
St. Paul's Hospital Millennium Medical College Éthiopie (code pays fourni par la source)Établissement de santé
-
College of Medicine and Health Sciences Department of Public health Debre Markos University, Éthiopie (pays nommé en fin d’affiliation)Université ou école supérieure
-
College of Health Sciences CDT-Africa Addis Ababa Univesity, Éthiopie (pays nommé en fin d’affiliation)Université ou école supérieure
-
School of Medicine Department of Biomedical Science Debre Markos University, Éthiopie (pays nommé en fin d’affiliation)Université ou école supérieure
-
St. Paul Millennium Medical College Addis Ababa, Éthiopie (pays nommé en fin d’affiliation)Université ou école supérieure
-
College of Natural and Computational Sciences Addis Ababa University, Éthiopie (pays nommé en fin d’affiliation)Université ou école supérieure
Debre Markos University (Debre Markos University, Éthiopie), Arba Minch University (Arba Minch University, Éthiopie) et University of Ottawa, avec 8 autres affiliations. Pays d’affiliation : Éthiopie.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.